Volume 3 – Advanced Heart Failure, Parts 1 & 2
Published 1 January 2009
Editors:
Order NowJames K. Kirklin, MD
Nicholas Banner, FRCP, FESC
Mariell Jessup, MD, FAHA, FACC, FESC
Members - $50.00 | Non-Members - $90.00
SECTION I: Introduction
Chapter 1: Introduction
Mariell Jessup
SECTION II: Pathophysiology of the Failing Heart
Chapter 2: Cellular and Subcellular Abnormalities
Risto Kerkelö and Thomas Force
Chapter 3: The Cardiac Interstitium
Ahmad Munir, Richard C. Davis, and Karl T. Weber
Chapter 4: Ventricular Remodeling in Advanced Heart Failure
John Harding and Thomas P. Cappola
Chapter 5:
Neurohormones and Cytokines in Heart Failure
James O. Mudd and Stuart D. Russell
Chapter 6: Exercise Intolerance in Heart Failure
Finn Gustafsson and Heather J. Ross
SECTION III: Cardiac Evaluation in the Patient with Advanced Heart Failure
Chapter 7: Clinical Assessment of Hemodynamic Status in Advanced Heart Failure
Lynne Warner Stevenson
Chapter 8: The Evolving Role for Hemodynamic Analysis in Heart Failure
David A. Kass
Chapter
9: The Role of Cardiac Catheterization in Patients Who have Advanced Heart Failure
Robert L. Wilensky and Ruchira Glaser
Chapter 10: Echocardiography
James N. Kirkpatrick
Chapter 11:
Nuclear and Positron Emission Tomography Imaging
Danilo Neglia and Alessia Gimelli
Chapter 12: Cardiovascular Magnetic Resonance
R. O'Hanlon and D.J. Pennell
Chapter 13: Computed Tomography
Edward D. Nicol, James E. Stirrup, and Michael B. Rubens
Chapter 14: The Role of ndomyocardial Biopsy in Advanced Heart Failure
Leslie T. Cooper, Jr.
Chapter 15: B-Type Natriuretic Peptide and
Other Natriuretic Factors
Roy S. Gardner and Theresa A. McDonagh
Chapter 16: Troponin and Other Biomarkers
Thomas J. Dengler, Evangelos Giannitsis and Hugo A. Katus
Chapter 17: Biomarkers and
Other Prognostic Schemas in Heart Failure
Wayne C. Levy
Chapter 18: Cardiopulmonary Exercise Testing in Advanced Heart Failure
Santiago Miriuka and Heather J. Ross
SECTION IV: Secondary Organ Dysfunction in Heart Failure
Chapter 19: The Cardiorenal Syndrome: Pathophysiology and Management
Michael R. Smith, Jie Li, Jigar Patel, and J. Thomas Heywood
Chapter 20: The Liver in Heart Failure
Arie J. Stangou and Nicholas R. BannerChapter 21: Cognitive Dysfunction in Patients with Chronic Heart Failure
Elaine M. Winkel, Walter G. Kao, Brian D. Juncker, and Maryl R. Johnson
Chapter 22: Skeletal Muscle Dysfunction and Deconditioning
in Heart Failure
Donna M. Mancini and Chim C. Lang
SECTION V: Stabilization of the Heart Failure Syndrome: First Steps and Initiating Maintenance
Chapter 23: Diuretics: Utility and Limitations
David S. Feldman, Terry S. Elton, and Kerry Pickworth
Chapter 24: Renin-Antiotensin-Aldosterone Antagonists: When, How Much, and Limiting Factors
Michael B.
Fowler
Chapter 25: ß-Blockers in Heart Failure: When to Start and When to Stop
Simon F. Shakar and JoAnn Lindenfeld
Chapter 26: Vasodilator Therapy in Advanced Heart Failure
Jennifer
R. Brown, Patricia A. Uber, and Mandeep R. Mehra
Chapter 27: Intravenous Inotropic Agents
Haifa Lyster and Nicholas R. Banner
Chapter 28: Anticoagulation and Antiplatelet Therapy in the Patient with
Advanced Heart Failure in Sinus Rhythm
Liviu Klein and John B. O'Connell
SECTION VI: Arrhythmias and Electrical Devices in the Patient with Advanced Heart Failure
Chapter 29: Atrial Fibrillation
David G. Jones and Vias Markides
Chapter 30: Cardiac Resynchronization Therapy
Zachary I. Whinnett, Darrel P. Francis, Jamil Mayet, and Nicholas S. Peters
Chapter 31: Implantable Cardioverter-Defibrillator Devices
E. Gronda, D. Pini and A. Municinò
Chapter 32: Management
of Recurrent Ventricular Arrhythmia
Matthew Wright, Ian Wright, and D. Wyn Davies
Chapter 33: Emergency Pacemakers in Advanced Heart Failure
Ralph J. Verdino
SECTION VII: Clinicopathological Correlations
Chapter 34: Acute Myocarditis: Diagnosis and Treatment
G. William Dec
Chapter 35: Giant Cell Myocarditis
Margaret M. Burke and Andrew G. Mitchell
Chapter 36: Amyloid Heart Disease
S.W. Dubrey and R.H. Falk
Chapter 37: Pericardial Disorders
Zuheir Abrahams, Hadi N. Skourie, Wilfried Mullens, Mohammad H. Yamani, and Randall C. Starling
SECTION VIII: Shock Complicating the Acute Coronary Syndrome
Chapter 38: Reperfusion and Failure of Reperfusion
H.S. Lim and J.N. Townend
Chapter 39: Myocardial Stunning
Rainer Zbinden and Michael Marber
Chapter 40: Mitral Regurgitation and Ventricular Septal Rupture After Myocardial Infarction
J.R. Pepper
Chapter 41: Shock Due to Catastrophic Loss of Myocardium
Stephen S. L. Tsui and Jayan Parameshwar
SECTION IX: Surgical Reparative Therapy
Chapter 42: Myocardial Revascularization for Heart Failure
J. Thekkudan, V.B. Dronavalli and R.S. Bonser
Chapter 43: Mitral Valve Regurgitation
G.D. Dreyfus
Chapter 44: Reverse Remodeling Procedures: Surgical Ventricular Restoration and Prosthetic Girdling Devices
Aaron S. Blom and Michael A. Acker
SECTION X: Other Therapies
Chapter 45: Intra-Aortic Balloon and Other Counterpulsation Techniques
Alistair C. Lindsay, Asghar Khaghani, and Miles C.D. Dalby
Chapter 46: Transplantation
Sharon A. Hunt
Chapter 47: Permanent Ventricular Assist Devices
Saba N. Khan and Marc A. Silver
Chapter 48: When Is Myocardial Failure Reversible
Nicholas R. Banner
SECTION XI: Supportive Care at End of Life
Chapter 49: Supportive and End-of-Life Care
Dale G. Renlund, Sally J. Brush, Kismet D. Rasmusson, and Abdallah G. Kfoury
SECTION XII: New Horizons
Chapter 50: New Horizons in the Treatment of Heart Failure
Kumudha Ramasubbu and Douglas L. Mann